The Science Behind Biosecurity
Now that Covid-19 has impacted the world, I sleep better knowing that many more people are losing sleep over the the need for robust biosecurity.
Read the post
The Science Behind Viral Vectors
In the old days, one person would write a letter (the genetic material), stick it in an envelope (the viral capsid), and mail it to someone who would open the envelope (bind with receptors) and read the letter (enter the cells).
Read the post
Get to Know James Oliviero, CEO and President of Checkpoint Therapeutics
BioSpace recently spoke with James Oliviero, CEO and president at Checkpoint Therapeutics, an immuno-oncology, late-stage development company.
Read the post
Let’s Get to Know Mir Imran, CEO and Chief Innovator at Rani Therapeutics
BioSpace recently spoke with Mir Imran, CEO and Chief Innovator at Rani Therapeutics, a company developing and testing a “robotic” pill that delivers biologics orally.
Read the post
Let’s Get to Know Yoav Kimchy, Founder and Chief Technology Officer of Check-Cap
BioSpace recently spoke with Yoav Kimchy, founder and chief technology officer of Check-Cap, a company developing the C-Scan® system to detect precancerous polyps.
Read the post
Get to Know Jonathan Rigby, Group CEO of Revolo Biotherapeutics
BioSpace recently spoke with Jonathan Rigby, Group CEO of Revolo Biotherapeutics, a biotherapeutic company working to revolutionize the treatment of autoimmune and allergic diseases by…
Read the post